Scaffold-mediated switching of lymphoma metabolism in culture

BACKGROUND: Diffuse large B cell lymphoma (DLBCL) is an aggressive subtype of non-Hodgkin lymphoma (NHL) and accounts for about a third of all NHL cases. A significant proportion (~40%) of treated DLBCL patients develop refractory or relapsed disease due to drug resistance which can be attributed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatt, Rachana, Ravi, Dashnamoorthy, Evens, Andrew M., Parekkadan, Biju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559005/
https://www.ncbi.nlm.nih.gov/pubmed/36224623
http://dx.doi.org/10.1186/s40170-022-00291-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559005/
https://www.ncbi.nlm.nih.gov/pubmed/36224623
http://dx.doi.org/10.1186/s40170-022-00291-y

Ejemplares similares